Global, regional, and national trends in the burden of chronic myeloid leukemia from 1990 to 2021: A comprehensive analysis of the 2021 global burden of disease study and projections to 2050
Comprehensive analysis shows rising chronic myeloid leukemia incidence in recent years, indicating critical public health needs.
Key Points
Chronic myeloid leukemia incidence rose globally, with age-standardized prevalence rates showing signs of concern over 32 years.
In 2021, the global age-standardized incidence rate for chronic myeloid leukemia was 0.43 per 100,000 population, reflecting notable health disparities.
Analysis of 32-year data used health inequality measures and decomposition analysis to assess chronic myeloid leukemia burden across settings.
Targeted public health strategies are crucial due to anticipated demographic shifts exacerbating chronic myeloid leukemia's impact.